StockData
COMPASS Pathways plc logo

COMPASS Pathways plc (CMPS) shareholders

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30
$8.27−0.74 (-8.21%)

Close on Nov 16, 2026Market cap $1.15BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
66.0%
91M of 138M shares
Institutional holders
223
63 new, 29 sold out
Net institutional buying
-2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Roderick Wong
Joint filing with RTW Investments, LP (9.90%)
12,971,5719.90%13G (passive) amendmentMar 31, 2026
David Kroin
Joint filing with Deep Track Capital, LP (9.99%), Deep Track Biotechnology Master Fund, Ltd. (9.99%)
9,274,5899.99%13G (passive)Jan 10, 2025
BIT Capital GmbH8,148,2805.90%13G (passive)Sep 30, 2026
RTW Investments, LP
Joint filing with Roderick Wong, M.D. (8.30%)
7,877,3498.30%13G (passive)Mar 31, 2025
ATAI Life Sciences AG
Joint filing with ATAI Life Sciences N.V. (7.50%)
6,905,7747.50%13D (active) amendmentMar 5, 2025
Vivo Opportunity Fund Holdings, L.P.
Joint filing with Vivo Opportunity, LLC (6.60%)
6,348,9886.60%13G (passive) amendmentMar 31, 2025
Wilmot B. Harkey
Joint filing with Nantahala Capital Management, LLC (6.23%), Daniel Mack (6.23%)
5,934,3156.23%13G (passive)Jun 30, 2025
ATAI Life Sciences N.V.5,785,7746.00%13D (active) amendmentOct 27, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CMPSValueChange% of portfolio
Deep Track Capital, LP12,161,4968.78%$172.09M–2.50%
Rtw Investments, LP10,700,9747.73%$151.42M+68,5841.29%
BIT Capital GmbH6,348,7974.58%$89.84M+2,857,5632.66%
Tang Capital Management LLC5,000,0003.61%$70.75M+997,8003.21%
Two Sigma Investments, LP4,470,4853.23%$63.26M+1,886,9860.05%
Marshall Wace, Llp4,328,6823.13%$61.25M+290,3470.05%
ARK Investment Management LLC3,451,9652.49%$48.85M+150,9150.32%
Point72 Asset Management, L.P.2,620,8781.89%$37.09MNew0.04%
Logos Global Management LP2,250,0001.62%$31.84MNew1.37%
Eagle Health Investments LP2,060,4271.49%$29.16M–4.83%
Bank Of America Corp /De/2,019,3481.46%$28.57M+1,987,0160.00%
DAFNA Capital Management LLC2,011,9521.45%$28.47M−406,9305.43%
NEXTBio Capital Management LP1,775,7591.28%$25.13M−245,64811.56%
Kalehua Capital Management LLC1,639,3841.18%$23.20M–7.40%
UBS Group AG1,482,4701.07%$20.98M−372,6000.00%
Aisling Capital Management LP1,432,3361.03%$20.27M–4.30%
Renaissance Technologies LLC1,431,8891.03%$20.26M+566,5350.03%
Candriam S.C.A.1,274,2780.92%$18.01MNew0.08%
Woodline Partners LP1,086,0040.78%$15.37M+910,5650.05%
Citadel Advisors LLC1,004,8800.73%$14.22M+735,3910.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202622391M66.0%63 / 7348 / 2924M26M
Q1 202619393M67.4%53 / 7126 / 2548M10M
Q4 202516855M39.7%37 / 3740 / 2512M12M
Q3 202515755M40.1%38 / 4924 / 1917M13M
Q2 202514052M37.5%25 / 3539 / 1913M13M
Q1 202513552M37.5%23 / 3927 / 1926M5M
Q4 202413231M22.3%32 / 2827 / 3010M11M
Q3 202413033M23.7%24 / 2729 / 158M5M
Q2 202412230M21.4%22 / 3020 / 145M3M
Q1 202411628M19.9%19 / 2626 / 268M3M
Q4 202312623M16.6%34 / 2130 / 214M3M
Q3 202311322M16.1%30 / 2118 / 1215M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

15 funds held CMPS in Q2 2026, 86% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of CMPSValue% of fundAs of
ARK Genomic Revolution ETF4,463,8753.22%$50.66M3.25%Jul 31, 2026
iShares Biotechnology ETF764,9430.55%$10.82M0.12%Jun 30, 2026
AdvisorShares Psychedelics ETF359,6470.26%$5.09M11.45%Jun 30, 2026
Royce Smaller-Companies Growth Fund178,0000.13%$2.52M1.06%Jun 30, 2026
Simplify Propel Opportunities ETF114,2810.08%$1.62M2.09%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF81,2790.06%$1.15M0.13%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund62,9620.05%$822.28K0.00%May 31, 2026
Dunham Small Cap Growth Fund62,5140.05%$709.53K0.89%Jul 31, 2026
AdvisorShares Dorsey Wright ADR ETF61,7000.04%$873.06K2.09%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund60,7530.04%$859.65K0.02%Jun 30, 2026
ROBO Global Healthcare Technology and Innovation ETF56,3580.04%$639.66K0.93%Jul 31, 2026
Tiff Multi-Asset Fund30,9310.02%$437.67K0.03%Jun 30, 2026
Old Westbury Small & Mid Cap Strategies Fund30,4890.02%$346.05K0.00%Jul 31, 2026
Virtus Biotech Clinical Trials Etf25,7310.02%$292.05K0.63%Jul 31, 2026
ActivePassive International Equity ETF21,4550.02%$280.20K0.03%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Kabir NathChief Executive Officer, Director361,0280.26%Aug 5, 2026
Guy GoodwinChief Medical Officer8,0000.01%Mar 27, 2026
Teri LoxamChief Financial Officer152,0020.11%Mar 27, 2026
Jeffrey M. JonasDirector––May 29, 2026
Wayne Joseph RileyDirector––May 29, 2026
Daphne KarydasDirector––May 29, 2026
Kathleen TregoningDirector––May 29, 2026
Gino SantiniDirector––May 29, 2026
David Y. NortonDirector20,3560.01%May 29, 2026
Robert McQuadeDirector––May 29, 2026
Justin D. GoverDirector––May 29, 2026
Annalisa JenkinsDirector19,4800.01%Jun 13, 2025
Linda McGoldrickDirector––Jun 13, 2025
Thomas LonngrenDirector89,0490.06%Jun 13, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Kabir Nath
Chief Executive Officer, Director
Aug 3, 2026Tax withholding−5,962$11.25$67.07K361,028
Teri Loxam
Chief Financial Officer
Mar 26, 2026Award+75,000––152,002
Kabir Nath
Chief Executive Officer, Director
Mar 26, 2026Award+175,000––366,990
Kabir Nath
Chief Executive Officer, Director
Mar 11, 2026Tax withholding−13,131$6.89$90.47K191,990
Teri Loxam
Chief Financial Officer
Mar 11, 2026Tax withholding−1,781$6.89$12.27K77,002
Teri Loxam
Chief Financial Officer
Mar 2, 2026Tax withholding−4,467$7.02$31.36K78,783
Kabir Nath
Chief Executive Officer, Director
Feb 2, 2026Tax withholding−16,181$6.61$106.96K205,121
Kabir Nath
Chief Executive Officer, Director
Aug 1, 2025Tax withholding−6,366$4.34$27.63K221,302
Kabir Nath
Chief Executive Officer, Director
Mar 11, 2025Award+92,000––227,668
Teri Loxam
Chief Financial Officer
Mar 11, 2025Award+25,000––83,250
Teri Loxam
Chief Financial Officer
Mar 3, 2025Tax withholding−4,468$3.67$16.40K58,250
Kabir Nath
Chief Executive Officer, Director
Feb 3, 2025Tax withholding−15,516$4.31$66.87K135,668
Ekaterina Malievskaia
10% owner
Oct 24, 2024Sale−776,565––3,155,122
Ekaterina Malievskaia
10% owner
Oct 24, 2024Sale−776,565––3,152,848
George Jay Goldsmith
10% owner
Oct 24, 2024Sale−776,565––3,152,848
George Jay Goldsmith
10% owner
Oct 24, 2024Sale−776,565––3,155,122
Life Sciences AG ATAI
10% owner
Sep 26, 2024Sale−2,660,000$6.05$16.09M6,905,774
Kabir Nath
Chief Executive Officer, Director
Aug 1, 2024Tax withholding−7,064$6.88$48.60K151,184
Annalisa Jenkins
Director
Aug 1, 2024Tax withholding−161$6.88$1.11K19,480
Ekaterina Malievskaia
10% owner
May 21, 2024Sale(10b5-1 plan)−8,900$7.91$70.40K3,931,687
Ekaterina Malievskaia
10% owner
May 21, 2024Sale(10b5-1 plan)−8,900$7.91$70.40K3,929,413
George Jay Goldsmith
10% owner
May 21, 2024Sale(10b5-1 plan)−8,900$7.91$70.40K3,929,413
George Jay Goldsmith
10% owner
May 21, 2024Sale(10b5-1 plan)−8,900$7.91$70.40K3,931,687
Ekaterina Malievskaia
10% owner
May 20, 2024Sale(10b5-1 plan)−6,703$7.89$52.89K3,940,587
Ekaterina Malievskaia
10% owner
May 20, 2024Sale(10b5-1 plan)−6,704$7.89$52.89K3,938,313
George Jay Goldsmith
10% owner
May 20, 2024Sale(10b5-1 plan)−6,704$7.89$52.89K3,938,313
George Jay Goldsmith
10% owner
May 20, 2024Sale(10b5-1 plan)−6,703$7.89$52.89K3,940,587
George Jay Goldsmith
10% owner
May 3, 2024Sale(10b5-1 plan)−18,762$8.82$165.48K3,947,290
George Jay Goldsmith
10% owner
May 3, 2024Sale(10b5-1 plan)−18,761$8.82$165.47K3,945,017
Ekaterina Malievskaia
10% owner
May 3, 2024Sale(10b5-1 plan)−18,762$8.82$165.48K3,947,290
Ekaterina Malievskaia
10% owner
May 3, 2024Sale(10b5-1 plan)−18,761$8.82$165.47K3,945,017
George Jay Goldsmith
10% owner
May 2, 2024Sale(10b5-1 plan)−9,621$8.29$79.76K3,966,052
George Jay Goldsmith
10% owner
May 2, 2024Sale(10b5-1 plan)−9,622$8.29$79.77K3,963,778
Ekaterina Malievskaia
10% owner
May 2, 2024Sale(10b5-1 plan)−9,622$8.29$79.77K3,963,778
Ekaterina Malievskaia
10% owner
May 2, 2024Sale(10b5-1 plan)−9,621$8.29$79.76K3,966,052
Annalisa Jenkins
Director
May 1, 2024Tax withholding−211$8.48$1.79K19,641
George Jay Goldsmith
10% owner
Apr 17, 2024Sale(10b5-1 plan)−10,850$8.78$95.26K3,975,673
George Jay Goldsmith
10% owner
Apr 17, 2024Sale(10b5-1 plan)−10,850$8.78$95.26K3,973,400
Ekaterina Malievskaia
10% owner
Apr 17, 2024Sale(10b5-1 plan)−10,850$8.78$95.26K3,975,673
Ekaterina Malievskaia
10% owner
Apr 17, 2024Sale(10b5-1 plan)−10,850$8.78$95.26K3,973,400
George Jay Goldsmith
10% owner
Apr 16, 2024Sale(10b5-1 plan)−23,880$8.53$203.70K3,984,250
George Jay Goldsmith
10% owner
Apr 16, 2024Sale(10b5-1 plan)−23,881$8.53$203.70K3,986,523
Ekaterina Malievskaia
10% owner
Apr 16, 2024Sale(10b5-1 plan)−23,881$8.53$203.70K3,986,523
Ekaterina Malievskaia
10% owner
Apr 16, 2024Sale(10b5-1 plan)−23,880$8.53$203.70K3,984,250
George Jay Goldsmith
10% owner
Apr 1, 2024Sale(10b5-1 plan)−25,750$8.96$230.72K4,010,404
George Jay Goldsmith
10% owner
Apr 1, 2024Sale(10b5-1 plan)−25,750$8.96$230.72K4,008,130
Ekaterina Malievskaia
10% owner
Apr 1, 2024Sale(10b5-1 plan)−25,750$8.96$230.72K4,010,404
Ekaterina Malievskaia
10% owner
Apr 1, 2024Sale(10b5-1 plan)−25,750$8.96$230.72K4,008,130
George Jay Goldsmith
10% owner
Mar 28, 2024Sale(10b5-1 plan)−25,750$8.65$222.74K4,036,154
George Jay Goldsmith
10% owner
Mar 28, 2024Sale(10b5-1 plan)−25,750$8.65$222.74K4,033,880
Ekaterina Malievskaia
10% owner
Mar 28, 2024Sale(10b5-1 plan)−25,750$8.65$222.74K4,036,154
Ekaterina Malievskaia
10% owner
Mar 28, 2024Sale(10b5-1 plan)−25,750$8.65$222.74K4,033,880
George Jay Goldsmith
Director, 10% owner
Mar 13, 2024Sale(10b5-1 plan)−17,203$10.80$185.79K4,061,904
George Jay Goldsmith
Director, 10% owner
Mar 13, 2024Sale(10b5-1 plan)−17,203$10.80$185.79K4,059,630
Ekaterina Malievskaia
Director, 10% owner
Mar 13, 2024Sale(10b5-1 plan)−17,203$10.80$185.79K4,059,630
Ekaterina Malievskaia
Director, 10% owner
Mar 13, 2024Sale(10b5-1 plan)−17,203$10.80$185.79K4,061,904
George Jay Goldsmith
Director, 10% owner
Mar 12, 2024Sale(10b5-1 plan)−15,740$10.58$166.53K4,079,107
George Jay Goldsmith
Director, 10% owner
Mar 12, 2024Sale(10b5-1 plan)−15,740$10.58$166.53K4,076,833
Ekaterina Malievskaia
Director, 10% owner
Mar 12, 2024Sale(10b5-1 plan)−15,740$10.58$166.53K4,076,833
Ekaterina Malievskaia
Director, 10% owner
Mar 12, 2024Sale(10b5-1 plan)−15,740$10.58$166.53K4,079,107

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
17M shares short
Days to cover
7.7
At 2M shares a day
Change since last report
-2.7%
From 18M shares
Short volume, 20 days
35.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of COMPASS Pathways's stock actually held short. Settlement fails (shares not delivered on time) peaked at 47,257 shares on Oct 7, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Annalisa Jenkins
Former Director
Aug 10, 202626,000$345.80KAug 10, 2026Stock Option Exercise
Annalisa Jenkins
Former Director
Aug 7, 202683,771$1.15MAug 7, 2026Stock Option Exercise
George Jay Goldsmith
Other: CEO & Co-founder
Mar 13, 2024432,291$4.61MMar 13, 2024Founder's Shares
Ekaterina Malievskaia
Other: CIO & Co-founder
Mar 13, 2024432,290$4.61MMar 13, 2024Founder's Shares
George Jay Goldsmith
Other: CEO & Co-founder
Dec 13, 2023309,000$2.22MDec 13, 2023Founder's Shares
Ekaterina Malievskaia
Other: CIO & Co-founder
Dec 13, 2023309,000$2.22MDec 13, 2023Founder's Shares

Congress trades

1 trade in COMPASS Pathways reported by 1 member of the House

MemberTypeTradedAmountFiled
Shri Thanedar
MI13
SoldJan 23, 2023$1K–15KFeb 9, 2023

See a number that looks wrong?